Health Condition 1: F40-F48- Anxiety, dissociative, stress-related, somatoform and other nonpsychotic mental disorders
Conditions
Interventions
None listed
Sponsors
Dr Savita Pawar
Eligibility
Inclusion criteria
Inclusion criteria: Women aged 45 to 55 years. Insomnia Severity Index. (ISI) (score in between 8-21 indicating sub threshold insomnia to moderate insomnia) Duration of insomnia greater than 1 month, greater than 3 nights/week. Able to understand and comply with CBT instructions. Give written informed consent. Mild to moderate case of insomnia.
Exclusion criteria
Exclusion criteria: Known cases of Hypertension, Thyroid disorders, and Diabetes Mellitus. PHQ-9 Depression scale Score greater than 5 Under medication for any psychological or psychiatric disorders, substance use. Habitual caffeine intake exceeding 400mg/day(equivalent to approximately 4 cups (240 ml each) of brewed coffee or any comparable caffeine sources Current insomnia treatment. Known case of pelvic pathology. Hormonal therapy. Severe case of insomnia. No access to mobile phones and internet.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Insomnia severity reduction: A clinically significant improvement defined as a greater than or equal to 7-point reduction in ISI score from baseline to 4 weeks. Sleep quality improvement: A greater than or equal to 3-point reduction in PSQI score from baseline to 4 weeks considered clinically meaningful. Timepoint: 4months | — |
Secondary
| Measure | Time frame |
|---|---|
| Insomnia severity reduction: A clinically significant improvement defined as a greater than or equal to 7-point reduction in ISI score from baseline to two weeks. Quality of life enhancement: A greater than or equal to 10% increase in Q-LES-Q-SF score from baseline to 4 weeks indicating improved satisfaction and enjoyment. Timepoint: 4 months | — |
Countries
India
Contacts
Public ContactDr Parvathy Unni Krishnan
Amrita school of ayurveda kerala india
Outcome results
None listed